Effectiveness of difluprednate in addition to systemic therapy for the treatment of anterior scleritis.

Paulina LibermanJennifer ThorneBryn BurkholderMeghan K Berkenstock

Published in: The British journal of ophthalmology (2023)

Most eyes treated with difluprednate achieved inactivity. The addition of difluprednate to systemic therapies provides an alternative to achieve control of inflammation.

Keyphrases

oxidative stress
systematic review
optical coherence tomography
combination therapy
drug induced